Amicus Therapeutics (Nasdaq: FOLD) has strengthened its executive leadership with the appointment of two new senior members of the commercial ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE